Personalized Cancer Vaccines Market Report

Global and Region Personalized Cancer Vaccines Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：211
  • REPORT CODE：GMM986378
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Personalized Cancer Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Personalized Cancer Vaccinesmarket, defines the market attractiveness level of Personalized Cancer Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Personalized Cancer Vaccines industry, describes the types of Personalized Cancer Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Personalized Cancer Vaccines market and the development prospects and opportunities of Personalized Cancer Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Personalized Cancer Vaccines market in Chapter 13.

    By Player:

    • Celldex

    • Gritstone Oncology

    • Genetech

    • Genocea

    • Hoffmann-La Roche Ltd

    • ISA Pharmaceuticals

    • Personalis

    • Advaxis Inc

    • CureVac AG

    • Moderna Therapeutics

    • Merck

    • BioNtech

    By Type:

    • By Cancer Type

    • Lung Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Leukemia

    • Prostate Cancer

    • Cervical Cancer

    • Glioblastoma

    • Others

    • By Mechanism of Action Type

    • Tumor-associated antigens (TAAs)

    • Tumor-specific antigens (TSAs)

    • Somatic Mutations in Cancer Pharmacogenomics

    • Pharmacogenomics towards Genomic Polymorphism

    By End-User:

    • Hospitals

    • Homecare

    • Specialty Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Personalized Cancer Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Personalized Cancer Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Personalized Cancer Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Personalized Cancer Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Personalized Cancer Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global Personalized Cancer Vaccines Consumption (2017-2022)

    • 7.2 United States Personalized Cancer Vaccines Consumption (2017-2022)

    • 7.3 Europe Personalized Cancer Vaccines Consumption (2017-2022)

    • 7.4 China Personalized Cancer Vaccines Consumption (2017-2022)

    • 7.5 Japan Personalized Cancer Vaccines Consumption (2017-2022)

    • 7.6 India Personalized Cancer Vaccines Consumption (2017-2022)

    • 7.7 South Korea Personalized Cancer Vaccines Consumption (2017-2022)

    8 Region and Country-wise Personalized Cancer Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 8.4 China Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 8.6 India Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea Personalized Cancer Vaccines Consumption Forecast (2022-2028)

    9 Global Personalized Cancer Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Personalized Cancer Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global By Cancer Type Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Leukemia Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Cervical Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Glioblastoma Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Others Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global By Mechanism of Action Type Consumption and Growth Rate (2017-2022)

      • 9.1.11 Global Tumor-associated antigens (TAAs) Consumption and Growth Rate (2017-2022)

      • 9.1.12 Global Tumor-specific antigens (TSAs) Consumption and Growth Rate (2017-2022)

      • 9.1.13 Global Somatic Mutations in Cancer Pharmacogenomics Consumption and Growth Rate (2017-2022)

      • 9.1.14 Global Pharmacogenomics towards Genomic Polymorphism Consumption and Growth Rate (2017-2022)

    • 9.2 Global Personalized Cancer Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Homecare Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Personalized Cancer Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global Personalized Cancer Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global By Cancer Type Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Leukemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Glioblastoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.10 Global By Mechanism of Action Type Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.11 Global Tumor-associated antigens (TAAs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.12 Global Tumor-specific antigens (TSAs) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.13 Global Somatic Mutations in Cancer Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.14 Global Pharmacogenomics towards Genomic Polymorphism Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Personalized Cancer Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Homecare Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Personalized Cancer Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Personalized Cancer Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Personalized Cancer Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Personalized Cancer Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Personalized Cancer Vaccines Market Competitive Analysis

    • 14.1 Celldex

      • 14.1.1 Celldex Company Details

      • 14.1.2 Celldex Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Celldex Personalized Cancer Vaccines Product and Service

    • 14.2 Gritstone Oncology

      • 14.2.1 Gritstone Oncology Company Details

      • 14.2.2 Gritstone Oncology Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Gritstone Oncology Personalized Cancer Vaccines Product and Service

    • 14.3 Genetech

      • 14.3.1 Genetech Company Details

      • 14.3.2 Genetech Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Genetech Personalized Cancer Vaccines Product and Service

    • 14.4 Genocea

      • 14.4.1 Genocea Company Details

      • 14.4.2 Genocea Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Genocea Personalized Cancer Vaccines Product and Service

    • 14.5 Hoffmann-La Roche Ltd

      • 14.5.1 Hoffmann-La Roche Ltd Company Details

      • 14.5.2 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product and Service

    • 14.6 ISA Pharmaceuticals

      • 14.6.1 ISA Pharmaceuticals Company Details

      • 14.6.2 ISA Pharmaceuticals Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 ISA Pharmaceuticals Personalized Cancer Vaccines Product and Service

    • 14.7 Personalis

      • 14.7.1 Personalis Company Details

      • 14.7.2 Personalis Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Personalis Personalized Cancer Vaccines Product and Service

    • 14.8 Advaxis Inc

      • 14.8.1 Advaxis Inc Company Details

      • 14.8.2 Advaxis Inc Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Advaxis Inc Personalized Cancer Vaccines Product and Service

    • 14.9 CureVac AG

      • 14.9.1 CureVac AG Company Details

      • 14.9.2 CureVac AG Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 CureVac AG Personalized Cancer Vaccines Product and Service

    • 14.10 Moderna Therapeutics

      • 14.10.1 Moderna Therapeutics Company Details

      • 14.10.2 Moderna Therapeutics Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Moderna Therapeutics Personalized Cancer Vaccines Product and Service

    • 14.11 Merck

      • 14.11.1 Merck Company Details

      • 14.11.2 Merck Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Merck Personalized Cancer Vaccines Product and Service

    • 14.12 BioNtech

      • 14.12.1 BioNtech Company Details

      • 14.12.2 BioNtech Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 BioNtech Personalized Cancer Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Personalized Cancer Vaccines

    • Figure Personalized Cancer Vaccines Picture

    • Table Global Personalized Cancer Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Personalized Cancer Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Personalized Cancer Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Personalized Cancer Vaccines Consumption by Country (2017-2022)

    • Figure United States Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Personalized Cancer Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global By Cancer Type Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Leukemia Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Cervical Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Glioblastoma Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global By Mechanism of Action Type Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor-associated antigens (TAAs) Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor-specific antigens (TSAs) Consumption and Growth Rate (2017-2022)

    • Figure Global Somatic Mutations in Cancer Pharmacogenomics Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacogenomics towards Genomic Polymorphism Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Homecare Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global By Cancer Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Leukemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cervical Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glioblastoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global By Mechanism of Action Type Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor-associated antigens (TAAs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor-specific antigens (TSAs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Somatic Mutations in Cancer Pharmacogenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacogenomics towards Genomic Polymorphism Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Personalized Cancer Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Personalized Cancer Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table Celldex (Foundation Year, Company Profile and etc.)

    • Table Celldex Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celldex Personalized Cancer Vaccines Product and Service

    • Table Gritstone Oncology (Foundation Year, Company Profile and etc.)

    • Table Gritstone Oncology Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gritstone Oncology Personalized Cancer Vaccines Product and Service

    • Table Genetech (Foundation Year, Company Profile and etc.)

    • Table Genetech Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genetech Personalized Cancer Vaccines Product and Service

    • Table Genocea (Foundation Year, Company Profile and etc.)

    • Table Genocea Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genocea Personalized Cancer Vaccines Product and Service

    • Table Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche Ltd Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Ltd Personalized Cancer Vaccines Product and Service

    • Table ISA Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table ISA Pharmaceuticals Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table ISA Pharmaceuticals Personalized Cancer Vaccines Product and Service

    • Table Personalis (Foundation Year, Company Profile and etc.)

    • Table Personalis Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Personalis Personalized Cancer Vaccines Product and Service

    • Table Advaxis Inc (Foundation Year, Company Profile and etc.)

    • Table Advaxis Inc Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advaxis Inc Personalized Cancer Vaccines Product and Service

    • Table CureVac AG (Foundation Year, Company Profile and etc.)

    • Table CureVac AG Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table CureVac AG Personalized Cancer Vaccines Product and Service

    • Table Moderna Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Moderna Therapeutics Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Moderna Therapeutics Personalized Cancer Vaccines Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Personalized Cancer Vaccines Product and Service

    • Table BioNtech (Foundation Year, Company Profile and etc.)

    • Table BioNtech Personalized Cancer Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioNtech Personalized Cancer Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US